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Background: Prediabetes awareness in adults has been associated with improved
weight management. Whether youth with prediabetes diagnosis experience similar
improvements is unknown.
Objective: To investigate the association between prediabetes identification and
body mass index (BMI) trajectory in overweight and obese adolescents.
Subjects: Youth who were followed longitudinally in a large academic-affiliated pri-
mary care network and who were overweight/obese while 10 to 18 years old.
Methods: Retrospective cohort study. Subjects were categorized as “screened” if at
least 1 hemoglobin A1c (HbA1c) result was available. Time series analysis was used
to determine the difference in difference (DID) in BMI Z-score (BMI-Z) slope before
and after HbA1c between: (a) screened youth found to have prediabetes-range
HbA1c (5.7%-6.4%, 39-46 mmol/mol) versus normal HbA1c and (b) screened versus
age-matched unscreened obese youth.
Results: A total of 4184 (55.6% female) screened subjects (median follow-up
9.7 years) were included. In which, 637 (15.2%) had prediabetes-range HbA1c. Predi-
abetes was associated with a greater decrease in BMI-Z slope than normal HbA1c
(DID: −0.023/year [95% CI: −0.042 to −0.004]). When compared to age-matched
unscreened subjects (n = 2087), screened subjects (n = 2815) experienced a greater
decrease in BMI-Z slope after HbA1c than unscreened subjects at a matched age
(DID: −0.031/y [95% CI -0.042 to −0.021]).
Conclusions: BMI-Z trajectory improved more among youth with prediabetes-range
HbA1c but also stabilized in screened youth overall. Prospective studies are needed
to identify provider- and patient-level drivers of this observation.
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1 | INTRODUCTION
Debate exists about the utility of screening for type 2 diabetes (T2D)
in overweight or obese adolescents due to the low prevalence of
undiagnosed T2D.1,2 However, prediabetes, an intermediate state of
glucose metabolism, occurs in approximately one-quarter of obese
youth.3 Although prediabetes in youth can be transient and related to
insulin resistance of puberty,4 it may also present an opportunity for
T2D risk reduction. In adults, awareness of prediabetes status is asso-
ciated with improvements in weight and glycemic status.5,6 Therefore,
Received: 25 January 2020 Revised: 4 March 2020 Accepted: 14 April 2020
DOI: 10.1111/pedi.13028
Pediatr Diabetes. 2020;21:743–746. wileyonlinelibrary.com/journal/pedi © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 743
we investigated whether prediabetes diagnosis by hemoglobin A1c
(HbA1c) screening is associated with improved body mass index (BMI)
trajectory in youth.
2 | METHODS
This retrospective cohort study of data from the Children’s Hospital of
Philadelphia (CHOP) Primary Care Network (2000—2018) was approved
by the CHOP Institutional Review Board. The cohort included non-
diabetic (by International Classification of Disease-9/10 codes, 249.x,
250.x; E08.x-E.11x., E13.x) youth who were overweight or obese (BMI
Z-score [BMI-Z] ≥1.04) when 10 to 18 years old. “Screened” youth were
those who underwent T2D screening via HbA1c between ages 10 to
18 years; if ≥1 HbA1c was available, only the first was considered.
“Unscreened” youth were those without available HbA1c result while
10 to 18 years old. All screened subjects had ≥1 BMI before and after
HbA1c. Unscreened obese youth were matched by age at start of follow
up with screened youth and had ≥1 BMI before and after the matched
age of the corresponding screened subject.
To minimize confounding of the relationship between BMI and
hyperglycemia, subjects were excluded if they were prescribed anti-
psychotics, frequent systemic glucocorticoids (>4 courses), or growth
hormone, or had a transplant of any type or cystic fibrosis. Follow-up
was from first to last BMI measurement or age 19 years. Among
screened subjects, two groups were defined by HbA1c: prediabetes
(5.7%-6.4%, 39-46 mmol/mol) and normal (<5.7%, <39 mmol/mol).
Subjects with HbA1c ≥6.5% (≥48 mmol/mol) were excluded to reduce
confounding due to hyperglycemia-related weight loss.
Prior to analysis, anthropometric measurements identified as
likely errors were excluded using an automated method.7-9 The pri-
mary outcome was change in age- and sex-adjustedBMI-Z10 trajectory
after HbA1c. To account for skewness, BMI-Z ≥1.96 were replaced
with a modified SD score.11
Time series analysis was used to determine the impact of:
(a) HbA1c result (normal vs prediabetes among the screened group)
and (b) the act of screening (screened vs unscreened) on BMI-Z trajec-
tory. Plots of unadjusted mean BMI-Z per year were generated to
depict trends by group. To account for intra-subject correlation, gen-
eralized estimating equations with autoregressive correlation struc-
ture and identity link were used, with BMI-Z as the dependent
variable. Independent variables included time before or after HbA1c,
indicator variable for pre/post-A1c, and HbA1c group (prediabetes vs
normal) or screened versus unscreened. The outcome of interest, dif-
ference in difference (DID) in BMI-Z slope between groups before
and after screening or matched age, was determined using an interac-
tion term between time, pre/post-screening, and group.12 The model
adjusted for BMI-Z at HbA1c, age at HbA1c, sex, race (Caucasian,
African American, Asian, multiple races, other), ethnicity (Hispanic,
Non-Hispanic), and insurance type (private, public).
Two sensitivity analyses were conducted. First, BMI, BMI-Z with-
out adjustment for extreme values, weight, and height (falsification test:
height trajectory would not be modifiable) were used as dependent
variables in separate models. Second, we repeated analyses using “nor-
mal” and “high” HbA1c of < or ≥6.0% (42 mmol/mol), based on clinical
recommendations at our institution to consider referral to Endocrinol-
ogy at that threshold, as well as the higher likelihood of persistent or
progressive dysglycemia above that threshold in adolescents.4
Analyses were conducted using Stata 14 (Stata Corporation, TX).
Descriptive analyses included means and standard deviations of con-
tinuous variables and distributions of categorical variables. Differ-
ences of means were assessed using Student’s t-test. Group
differences in categorical variables were assessed using Pearson’s chi-
squared test. Two-sided hypothesis tests were used; P < 0.05 was
considered statistically significant.
3 | RESULTS
After exclusion of 18 subjects with diabetes-range HbA1c, the
screened cohort included 4184 (n = 2327, 55.6% female) adolescents
followed for a median of 9.7 years (IQR 8.0-10.7), contributing
38 694 BMIs, with a median follow-up of 2.3 (IQR 1.4-3.0) years after
HbA1c measurement. 637 (15.2%) had prediabetes-range HbA1c
(mean [SD] 5.9% (0.1%), 41 (1) mmol/mol). Mean age at testing was
slightly higher among those with normal HbA1c (13.2 [95% CI
13.1-13.3] vs 12.9 [95% CI 12.8-13.1] years). Weight, BMI, and BMI
Z-score were higher among the prediabetes group at testing (all
P < 0.005). Gender distribution was not different (P = 0.2). The predia-
betes group had more African American youth (64% vs 42%,
P < 0.0001).
BMI-Z was similar at start of follow-up (P = 0.5), gradually diverged,
then plateaued (normal HbA1c) or decreased (prediabetes) after HbA1c
(Figure 1A). In time series analysis, BMI-Z increase was significantly
greater among the prediabetes group than the normal HbA1c group prior
to screening (0.061/y [95% CI 0.049-0.073] vs 0.036/y [95% CI
0.030-0.042]). Post-HbA1c, both had significantly decreased slopes (pre-
diabetes: 0.011/y [95% CI -0.006-0.029] vs normal: 0.009/y [95% CI
0.002-0.017]), but the improvement was greater in the prediabetes
group: pre/post difference of −0.050/y (prediabetes) versus −0.027 (nor-
mal), DID = −0.023/y (95% CI: −0.042 to −0.004).
To assess the impact of screening regardless of result, 2815
screened subjects were age-matched with 2087 unscreened obese
subjects. Screened subjects were more often female (55.3% vs 41.7%,
P < 0.001) and African American (46.3% vs 30.6%, P < 0.001).
Screened subjects had a plateau in BMI-Z after screening, while
unscreened did not after matched age (Figure 1B). Adjusting for
BMI-Z at HbA1c (or matched age), sex, age, race, ethnicity, and insur-
ance type, BMI-Z slope decreased more in the screened than the
unscreened group (DID: −0.031/y [95% CI -0.042 to −0.021]).
3.1 | Sensitivity analyses
Among the screened cohort, a greater improvement in slope in the
prediabetes group was again found for BMI and unmodified BMI-Z,
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but not for weight or height (BMI DID: −0.13/y [95% CI -0.23 to
−0.03]; unmodified BMI-Z DID: −0.013/y [95% CI -0.025 to −0.001]).
The differential reduction in BMI-Z slope was even greater when a
higher HbA1c threshold to define “abnormal” was used:
DID = −0.049/y (95% CI -0.082 to −0.015).
4 | DISCUSSION
To our knowledge, this is the first study to report an improved BMI
trajectory after prediabetes identification in overweight and obese
youth. In addition, our demonstration of greater slowing of BMI-Z
gain after screening versus no screening suggests that the act of
screening may have value even if results are normal. Our study has
several strengths, including the large, diverse cohort of adolescents
screened by HbA1c, a median follow-up of nearly a decade, and use
of a robust algorithm to identify implausible growth data.
One possible explanation for the greater improvement in BMI trajec-
tory after prediabetes diagnosis is intrinsic motivation due to perceived
risk.13 Alternatively, differences in counseling by pediatricians may be
operative. If elucidated, the factors responsible for this differential
improvement could be harnessed to increase the utility of identifying pre-
diabetes in adolescents. The differential improvement among screened
versus unscreened patients may reflect actions taken by pediatrician at
the time of screening. This should be further explored to determine
whether the act of ordering screening, beyond any associated counseling,
is necessary to achieve the observed improvement in BMI trajectory.
We acknowledge limitations, including the inability to determine
how prediabetes diagnosis was conveyed or patients counseled. We
were unable to assess (a) patient-level factors influencing completion
of ordered screening tests or (b) provider-level factors related to
screening some obese adolescents but not others, but we suspect
additional risk factors, such as higher-risk race/ethnicity, informed
some decision-making.14 In addition, our findings are limited to predi-
abetes defined by HbA1c, which is 0.3% to 0.4% higher in African
American compared to White non-diabetic adults even after adjust-
ment for age and adiposity and does not have 100% concordance
with fasting glucose and oral glucose tolerance tests.15,16 Nonethe-
less, HbA1c is widely used for diabetes screening in pediatric prac-
tice.17 Finally, the possible concurrent identification of other obesity-
or family-related health risks was not investigated in this study. How-
ever, a previous study using data from the same primary care network
F IGURE 1 Mean BMI Z-score by year before and after initial HbA1c. Vertical line at “0” indicates screening HbA1c. Line and gray bands
represent linear regression line fit and associated 95% confidence intervals. A, Full screened cohort and B, age-matched screened and unscreened
cohort
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found that routine lipid screening was not associated with altered
BMI trajectory in overweight and obese youth.18
Whether results from T2D screening in overweight and obese
adolescents can be leveraged to promote BMI improvement is
unknown, but our findings suggest that HbA1c-based screening may
be useful beyond its intended goal of T2D identification.
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